A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Clinical trial NCT03969329 · RECRUITING

Trial details

NCT number: NCT03969329
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism

Start date: 2019-12-20
Primary completion: 2027-06-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.